Anpario (LON:ANP) Sets New 12-Month High – Should You Buy?

Anpario plc (LON:ANP) shares hit a new 52-week high on Monday . The stock traded as high as GBX 437 ($5.34) and last traded at GBX 431.60 ($5.27), with a volume of 124569 shares trading hands. The stock had previously closed at GBX 407.66 ($4.98).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group lifted their target price on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a report on Wednesday, September 18th.

Anpario Price Performance

The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of £72.98 million, a P/E ratio of 2,397.78 and a beta of 0.58. The company has a 50 day moving average of GBX 357.55 and a 200-day moving average of GBX 320.30.

Insider Activity at Anpario

In other news, insider Karen Prior sold 14,000 shares of the company’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total transaction of £53,200 ($64,949.33). 30.51% of the stock is currently owned by corporate insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.